Fluvoxamine is widely used to treat depression during pregnancy and lactation. This case series provides additional information on the infant's exposure to fluvoxamine during pregnancy and lactation. #MedSafetyWeek https://t.co/q4ofrIauJi
With this study, Anaëlle Monfort et al provide evidence that will help women and their healthcare providers make more informed decisions on the safety of one of the most common antidepressants. Read the paper 👇👇👇https://t.co/q4ofrIb2yQ
RT @karelallegaert: Maternal fluvoxamine results in transplacental and lactation-associated infant drug exposure as the drug level at birth…
Maternal fluvoxamine results in transplacental and lactation-associated infant drug exposure as the drug level at birth is not zero in the infant. Integrated analysis of umbilical cord blood and postnatal data needed. IMI Conception effort ! open access, h